- Category
- Micro (2022-23)
- Udyam number
- UDYAM-TN-08-0047853

About Xeno Pharmaaceuticals Private Limited
Data last updated:
Xeno Pharmaaceuticals Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 March 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U33112TN2009PTC071160. Its GSTIN is 33AAACX0733E1ZU (Tamil Nadu).
The company has an authorised share capital of ₹40 Lakh and a paid-up capital of ₹40 Lakh. It is led by directors Palani Vel Sakthivel (Managing Director) and Muthukrishnan Mahendrakumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No 87 A 8th Street Shree Kumaran Nagar Kovur, Chennai, Tamil Nadu, India – 600128.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.68 Cr, a growth of 34% compared to the previous year. For the same year it recorded a net profit of ₹5.84 Lakh (net margin 1.6%) and EBITDA of ₹31.17 Lakh (EBITDA margin 8.5%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years and 1% over five years.
The company has about 8 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹2 Cr and satisfied charges of ₹1.5 Cr on record.
Xeno Pharmaaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-08-0047853). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website xenopharma.in.
Company details
Recognitions & Rankings of Xeno Pharmaaceuticals
Contact details
Xeno Pharmaaceuticals Private Limited's registered office is in Chennai, Tamil Nadu. Its website is xenopharma.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressNo 87 A 8th Street Shree Kumaran Nagar Kovur, Chennai, Tamil Nadu, India – 600128
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Xeno Pharmaaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Xeno Pharmaaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Xeno Pharmaaceuticals Private Limited, buy the company report.
Financials of Xeno Pharmaaceuticals Private Limited
FY 2025 filings availableXeno Pharmaaceuticals Private Limited reported revenue of ₹3.68 Cr (up 34% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 1% over five years, including 34% growth in the latest year. EBITDA rose 39% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹31.17 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.84 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.5% | ||||
| Net Profit Margin | 1.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Xeno Pharmaaceuticals Private Limited, buy the company report.
Board of directors of Xeno Pharmaaceuticals Private Limited
Xeno Pharmaaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Palani Vel Sakthivel | Managing Director | 27 Mar 2009 | 17 Years 7 Months | Current |
| Muthukrishnan Mahendrakumar | Director | 27 Mar 2009 | 17 Years 7 Months | Current |
Auditor
Xeno Pharmaaceuticals Private Limited is audited by AR ANNAMALAI & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AR ANNAMALAI & CO | FY 2020 | 000207S |
Shareholding
The shareholding of Xeno Pharmaaceuticals Private Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Xeno Pharmaaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 22 Jun 2021 | 100454153 | Others | ₹1 Cr | Open | |
| 07 Jun 2021 | 100451387 | Others | ₹1 Cr | Open | |
| 27 Jun 2016 | 100066630 | Others | ₹1.5 Cr | Satisfied |
To see the full charge records of Xeno Pharmaaceuticals Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
No court or tribunal cases involving Xeno Pharmaaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Xeno Pharmaaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Xeno Pharmaaceuticals Private Limited has a workforce of 8 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
GST
Xeno Pharmaaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAACX0733E1ZU | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Xeno Pharmaaceuticals Private Limited, buy the company report.
Recent activity
Xeno Pharmaaceuticals Private Limited has 4 board changes on record since 2009: 2 appointments and 2 cessations. The latest: Muthukrishnan Mahendrakumar ceased to be Managing Director on 12 Oct 2018.
Frequently asked questions
Xeno Pharmaaceuticals is an active private limited company based in Chennai, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 March 2009 (17+ years old) and is registered under CIN U33112TN2009PTC071160.
Xeno Pharmaaceuticals has 2 current directors:
- Palani Vel Sakthivel - Managing Director
- Muthukrishnan Mahendrakumar - Director
The latest financial statements of Xeno Pharmaaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Xeno Pharmaaceuticals is 33AAACX0733E1ZU, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Xeno Pharmaaceuticals is U33112TN2009PTC071160. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Xeno Pharmaaceuticals was incorporated on 27 March 2009, making it 17+ years old. It is registered with the Registrar of Companies, Chennai.
Muthukrishnan Mahendrakumar ceased to be Managing Director on 12 Oct 2018. Palani Vel Sakthivel ceased to be Director on 12 Oct 2018. Muthukrishnan Mahendrakumar was appointed as Director on 27 Mar 2009. Xeno Pharmaaceuticals has 4 board changes on record in total.
Yes, Xeno Pharmaaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TN-08-0047853).
Xeno Pharmaaceuticals can be reached through the website xenopharma.in. Its registered office is in Chennai, Tamil Nadu, India.
The registered office of Xeno Pharmaaceuticals is at No 87 A 8th Street Shree Kumaran Nagar Kovur, Chennai, Tamil Nadu, India – 600128.

